Servei de Pneumologia, Hospital Clinic
Barcelona, 08036, Spain
NCT Number: NCT00364299
Background: The aspiration of contaminated secretions pooled above the endotracheal tube cuff secondary to inadvertent falls of cuff pressure is the main pathogenic mechanism of ventilator-associated pneumonia (VAP). Aim of the study: To assess the efficacy of an automatic device for the continuous regulation of tracheal tube cuff pressure in decreasing the incidence of VAP.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Barcelona, 08036, Spain
Design: Prospective, randomized, controlled trial, with 2 groups: study (automated control of cuff pressure) and control (standard control of cuff pressure). Setting: Respiratory Intensive Care Unit (RICU). Subjects: Patients >18 yr, intubated and ventilated. Interventions and measurements: Study group (cuff pressure will be kept constant at 25 cmH2O with the automatic device) and control group (cuff pressure control every 8 h. at the same level using a manual pressure controller, according with standard routine); recording of clinical variables at admission and during RICU stay, and end-point variables (incidence of VAP, etiologic microorganisms, RICU and hospital stay, RICU and 60-d mortality. Expected results: Lower incidence of VAP in study group, compared with control group.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hospital Clinic of Barcelona
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07482007
Cross Infection, Disease Attributes
Tanta, Egypt
View Trial DetailsNCT07013032
Cross Infection, Disease Attributes
Konya, Karatay, Turkey (Türkiye)
View Trial DetailsNCT07509697
Artificial Intelligence (AI), Bacterial Infections
Yenimahalle, Ankara, Turkey (Türkiye)
View Trial DetailsNCT04700202
Cross Infection, Disease Attributes
Dallas, Texas, United States
View Trial Details